Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Global Conference in Canada
-
Is Q 652 and its response still valid? Is an international conference still required to meet the following criteria to have it considered to be outside of PAAB prevue? The updated "Distinction between advertising..." document was updated in 2023 and doesn't explicitly say the following:
The conference must clearly be an international event, e.g., a significant proportion of the conference delegates are from other jurisdictions,
II. the material must emanate from the parent company of the manufacturer,
III. the material must only be for use within the confines of the conference, and
IV. the material is prominently identified as not being authorized for sale in Canada.Kindly confirm and thanks!
-
